Senior insider sale
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC — senior position signals high conviction
$299.1K
3.67K shares
What this filing means
COLE G BRADLEY plans to sell 3.67K shares of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC valued at approximately $299.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/29/2026ACC: 0001921094-26-000767
Director
Since Jul 2020
3.67K
Shares to sell
$299.1K
Approx. market value
3.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Lapse
Equity Compensation
6/5/2025
3.17KRestricted Stock Lapse
Equity Compensation
6/29/2023
500.00Total acquired3.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2025 | Restricted Stock Lapse Equity Compensation | 3.17K | — |
6/29/2023 | Restricted Stock Lapse Equity Compensation | 500.00 | — |
| Total | 3.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.67K
Market value
$299.1K
7/29/2026
Total
Units
3.67K
Value
$299.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/29/2026 | 3.67K | $299.1K | NASDAQ | Planned |
| Total | 3.67K | $299.1K | ||